The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Webcasts

Webinar Date/Time:  Tue, Nov 4, 2025 12:00 PM EST

Navigating the Transition to Next-Generation Propellants in Inhalation Drug Development

Mike Hennessy Jr. is the Chairman and CEO of 

Articles

This issue showcases strategies that organizations are adopting to stay competitive as pressing industry trends shape the sector.

From Discovery to Delivery: Evolving Practices in Pharma

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

AstraZeneca’s $4.5 billion investment in Virginia expands its US drug manufacturing footprint, creating 3600 jobs and integrating AI for cancer and metabolic therapies.

AstraZeneca’s US Expansion Highlights AI, Automation, and Policy Pressure in Pharma Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The increasing diversity and complexity of injectable drug products is driving innovation.

Advances in Digitalization and Automation of Aseptic Processing

Webinar Date/Time:  Wed, Nov 5, 2025 11:00 AM EST

Unlocking precision: The role of GMP-grade solvents in Antibody Drug Conjugate Manufacturing

Webinar Date/Time:  Wed, Nov 12, 2025 11:00 AM EST

From Isotope to Injection: Managing Risk and Compliance in Radiopharmaceutical Development

The new label for prefilled syringes, in conjunction with innovations from SCHOTT Pharma, enables integrated tamper-evidence and digital tracking across the supply chain.

What Schreiner MediPharm’s RFID-Embedded Label Launch at CPHI Frankfurt Means for Manufacturing

Feliza Mirasol is the science editor for 

At the Cell and Gene Meeting on the Mesa, a panel discussion was held on advanced therapy production and how it demands modular platforms, automation, and data governance to drastically improve patient access and affordability.

The Importance of Building in Flexibility and Commercial Viability Early in the CGT Scaling Process

 is Global Strategic Marketing Manager, Roquette.

, is Application and Innovation Technical Service Manager, Roquette.

The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing options.

Enhancing Patient-Centric Care Through Oral Liquid Drug Delivery Formulations

This article takes a look at the developing use of AI in pharmaceutical development and manufacturing.